HOME >> MEDICINE >> NEWS
When It Comes To Heart Attacks, Size Apparently Does Matter

NEW ORLEANS-- Just how do doctors figure out if a new drug for heart disease is effective? Most trials look at whether the drug reduces the number of deaths and heart attacks in group of patients taking it, compared to patients who don't.

But what if the drug turns a large heart attack, one that could potentially kill the patient, into a smaller heart attack that does less damage? Under the traditional way of testing medicines, the drug wouldn't be deemed effective, because it didn't reduce the number of heart attacks.

And that's far from an academic matter, say researchers at Duke University Medical Center, who argue that the way cardiology trials are conducted should be changed.

"Just counting the number of heart attacks may be the wrong way to measure a drug's effectiveness," says Dr. John Alexander, who prepared the results of his analysis for presentation Sunday at the annual scientific sessions of the American College of Cardiology.

"The fact that we may be able to reduce the size of myocardial infarction (MI) without necessarily reducing the incidence may be very important clinically," said Alexander, a cardiologist at the Duke Clinical Research Institute (DCRI).

Alexander based his findings on a close examination of data from the recently completed 10,948-patient PURSUIT trial of the drug eptifibatide (Integrilin), which was funded by the drug manufacturer, COR Therapeutics Inc., of San Francisco. He and his team found that while the drug slightly reduced the number of myocardial infarctions, it also reduced the size of MIs, possibly by converting larger ones into smaller ones.

Like many studies in heart disease, PURSUIT used the occurrence of an MI -- the death of heart muscle from the sudden loss of blood supply -- as a key part of the principal measurement of whether or not the patient benefited from the therapy. Since not all MIs are clear-cut, however, a committee of cardiologists not involved
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
7-Mar-1999


Page: 1 2 3

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Heart surgeons publish death rates
3. Heart attack treatment gap may be closing for women
4. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
5. Brenner Childrens Hospital named to NIH Pediatric Heart Network
6. Heart patients treated by non-cardiologists less likely to receive medications
7. Heart failure patients treated for diabetes with insulin have increase in mortality
8. New research results: Heart jacket shown to be effective
9. Heart surgery patients receive less aggressive discharge care
10. Heart attack, stroke risk overlooked in diabetics
11. Heart arrhythmias easily treated, yet few know risks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... , ... The American Board of Family Medicine's (ABFM) Board of Directors has ... succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the ... at the end of 2018. Upon assuming the role of President and CEO on ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
Breaking Medicine Technology:
Cached News: